Published in Br J Pharmacol on February 01, 2000
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57
A simple, rapid, and sensitive DNA assay procedure. Anal Biochem (1980) 23.88
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell (1997) 12.83
Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem (1993) 10.95
Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem Sci (1990) 6.45
Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol (1999) 6.24
The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol (1998) 5.96
Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J (1998) 5.05
Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun (1989) 4.63
An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett (1989) 3.10
Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci U S A (1981) 2.96
Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem (1999) 2.76
Mitochondria and apoptosis. Eur J Biochem (1998) 2.58
A malachite green colorimetric assay for protein phosphatase activity. Anal Biochem (1991) 2.19
Caspases: key mediators of apoptosis. Chem Biol (1998) 1.87
Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc Natl Acad Sci U S A (1994) 1.59
The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res (1991) 1.55
P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol (1996) 1.46
Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Toxicon (1994) 1.23
Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia (1992) 1.12
Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues. Biochem Pharmacol (1993) 1.11
Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes (1998) 1.04
Function and regulation of the human multidrug resistance gene. Adv Cancer Res (1993) 0.99
Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane. Proc Natl Acad Sci U S A (1994) 0.96
Characterization of the PP2A alpha gene mutation in okadaic acid-resistant variants of CHO-K1 cells. Proc Natl Acad Sci U S A (1994) 0.89
Characterization of two pituitary GH3 cell sublines partially resistant to apoptosis induction by okadaic acid. Biochem Pharmacol (1997) 0.81
Gene amplification and multidrug resistance induced by the phosphatase-inhibitory tumor promoter, okadaic acid. Carcinogenesis (1995) 0.80
Phosphatase inhibitors induce defective hormone secretion in insulin-secreting cells and entry into apoptosis. Exp Clin Endocrinol Diabetes (1999) 0.80
Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett (1993) 0.79
Chinese hamster ovary cells resistant to okadaic acid express a multidrug resistant phenotype. Biochem Biophys Res Commun (1994) 0.78
Inhibitors of ser/thr phosphatases 1 and 2A induce apoptosis in pituitary GH3 cells. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.78
Establishment of a human small-cell lung-cancer subline resistant to okadaic acid. Int J Cancer (1994) 0.77
Therapeutic strategies involving the multidrug resistance phenotype: the MDR1 gene as target, chemoprotectant, and selectable marker in gene therapy. Adv Pharmacol (1999) 0.77
Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 14.84
Smoking in China: findings of the 1996 National Prevalence Survey. JAMA (1999) 8.67
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res (1997) 7.95
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill (2010) 3.15
Leukotrienes in the pathophysiology of kwashiorkor. Lancet (1993) 3.14
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS (1997) 2.82
Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem (1998) 2.72
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum (2009) 2.57
Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster. Science (2001) 2.40
Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus. Clin Chem (1999) 2.26
Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J Clin Microbiol (1998) 2.23
Rapid cloning by homologous recombination in vivo. Nucleic Acids Res (1993) 2.19
Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol (1996) 2.14
Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis (2001) 2.14
Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control (2001) 2.10
Endoscopic closure of esophageal intrathoracic leaks: stent versus endoscopic vacuum-assisted closure, a retrospective analysis. Endoscopy (2013) 2.08
Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur J Clin Microbiol Infect Dis (2009) 2.04
Formation of complexes between polyvinyl pyrrolidones or polyethylene glycols and tannins, and their implication in gas production and true digestibility in in vitro techniques. Br J Nutr (1995) 1.96
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut (2007) 1.90
Hydrothermal recharge and discharge across 50 km guided by seamounts on a young ridge flank. Nature (2003) 1.79
Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill (2014) 1.79
Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha. Mol Cell Biol (1988) 1.77
Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur J Clin Microbiol Infect Dis (2009) 1.76
Detection of fat in a renal cell carcinoma mimicking angiomyolipoma. Radiology (1993) 1.75
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity (1997) 1.74
Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem (2000) 1.70
Influence of cold ischemia time, pretransplant anti-porcine antibodies, and donor/recipient size matching on hyperacute graft rejection after discordant porcine to cynomolgus kidney transplantation. Transplantation (2000) 1.69
Research for effective global tobacco control in the 21st century: report of a working group convened during the 10th World Conference on Tobacco or Health. Tob Control (1998) 1.64
The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited. J Biol Chem (2000) 1.63
PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin Exp Allergy (2007) 1.59
On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes. J Exp Med (1987) 1.58
Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol (2001) 1.56
The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.56
Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise-induced myolysis. Br J Anaesth (1991) 1.53
Idiotypic regulation of the immune system. Common idiotypic specificities between idiotypes and antibodies raised against anti-idiotypic antibodies in rabbits. J Exp Med (1979) 1.51
Cross-border comparison of the admission prevalence and clonal structure of meticillin-resistant Staphylococcus aureus. J Hosp Infect (2009) 1.50
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48
Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. Anesthesiology (1995) 1.46
Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs. Br J Anaesth (1990) 1.44
Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta (1976) 1.44
Low-dose cost/benefit assessment--a view from Europe. Health Phys (1998) 1.42
Epinephrine application via an endotracheal airway and via the Combitube in esophageal position. Crit Care Med (2000) 1.41
Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br (2007) 1.40
Hemodynamic consequences of porcine kidney xenograft reperfusion in cynomolgus monkeys. Transplantation (2001) 1.39
Keratin 9 mutations in the coil 1A region in epidermolytic palmoplantar keratoderma. Pediatr Dermatol (2000) 1.38
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res (1994) 1.36
Systemic dry cow therapy--a preliminary report. J Dairy Sci (1990) 1.36
The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia (1984) 1.35
[Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg (1987) 1.35
Virulence factors and genotypes of Staphylococcus aureus from infection and carriage in Gabon. Clin Microbiol Infect (2011) 1.33
Outbreak of 2009 pandemic influenza A(H1N1), Los Lagos, Chile, April-June 2009. Euro Surveill (2010) 1.32
Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit (1995) 1.30
Presence and phosphorylation of transcription factors in developing dendrites. Proc Natl Acad Sci U S A (1998) 1.30
Twenty years of the German Environmental Survey (GerES): human biomonitoring--temporal and spatial (West Germany/East Germany) differences in population exposure. Int J Hyg Environ Health (2007) 1.30
Pharmacokinetics of azlocillin in persons with normal and impaired renal functions. Antimicrob Agents Chemother (1978) 1.28
Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy. Mol Cell Biol (2001) 1.28
Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J Clin Microbiol (1994) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
EUREGIO MRSA-net Twente/Münsterland--a Dutch-German cross-border network for the prevention and control of infections caused by methicillin-resistant Staphylococcus aureus. Euro Surveill (2008) 1.27
Protein folding causes an arrest of preprotein translocation into mitochondria in vivo. J Cell Biol (1991) 1.26
Thyroid hormone inhibition of human thyrotropin beta-subunit gene expression is mediated by a cis-acting element located in the first exon. J Biol Chem (1989) 1.26
mRna expression analysis of tissue sections and single cells. J Neurosci (2001) 1.25
FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. J Exp Med (2000) 1.24
Analysis of cellular factors influencing the replication of human immunodeficiency virus type I in human macrophages derived from blood of different healthy donors. Virology (2001) 1.23
A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J (1998) 1.23
The thioredoxin system of Plasmodium falciparum and other parasites. Cell Mol Life Sci (2002) 1.22
Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy (2010) 1.21
The putative glutathione peroxidase gene of Plasmodium falciparum codes for a thioredoxin peroxidase. J Biol Chem (2000) 1.20
Long-acting growth hormones produced by conjugation with polyethylene glycol. J Biol Chem (1996) 1.19
Monooxygenases as biocatalysts: Classification, mechanistic aspects and biotechnological applications. J Biotechnol (2010) 1.18
Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol (1996) 1.18
Serum thyrotrophin determination on day 5 of life as screening procedure for congenital hypothyroidism. Arch Dis Child (1977) 1.17
Cysts in left atrial myxomas identified by transesophageal cross-sectional echocardiography. Am J Cardiol (1983) 1.15
The German Environmental Survey 1990/1992 (GerES II): reference concentrations of selected environmental pollutants in blood, urine, hair, house dust, drinking water and indoor air. J Expo Anal Environ Epidemiol (2001) 1.15
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding. Cell Death Differ (2009) 1.12
Mitochondrial protein import: specific recognition and membrane translocation of preproteins. J Membr Biol (1993) 1.12
Effect of various domestic processing methods on antinutrients and in vitro protein and starch digestibility of two indigenous varieties of Indian tribal pulse, Mucuna pruriens Var. utilis. J Agric Food Chem (2001) 1.11
Edible provenances of Jatropha curcas from Quintana Roo state of Mexico and effect of roasting on antinutrient and toxic factors in seeds. Plant Foods Hum Nutr (1998) 1.11
Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect (1999) 1.10
Bioactivity of phytochemicals in some lesser-known plants and their effects and potential applications in livestock and aquaculture production systems. Animal (2007) 1.10
Studies on the nutritional composition and antinutritional factors of three different germplasm seed materials of an under-utilized tropical legume, Mucuna pruriens var. utilis. J Agric Food Chem (2000) 1.09
Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses (2003) 1.08
Antigen trafficking and accessory cell function in respiratory epithelial cells. Am J Respir Cell Mol Biol (1999) 1.08
Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J Clin Invest (1998) 1.08
Effect of polyethylene glycol on in vitro degradability of nitrogen and microbial protein synthesis from tannin-rich browse and herbaceous legumes. Br J Nutr (2000) 1.08
Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett (1998) 1.07
Fibrovascular esophageal polyp as a diagnostic challenge. Dis Esophagus (2000) 1.07
Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS. Clin Exp Immunol (2001) 1.07
New epidemiology of Staphylococcus aureus infection in Africa. Clin Microbiol Infect (2014) 1.07
Impact of modified acidic soft drinks on enamel erosion. Oral Dis (2005) 1.06
Changes in microbial community structure, methanogenesis and rumen fermentation in response to saponin-rich fractions from different plant materials. J Appl Microbiol (2008) 1.06
Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Bioorg Med Chem Lett (2006) 1.05
The degradability characteristics of fifty-four roughages and roughage neutral-detergent fibres as described by in vitro gas production and their relationship to voluntary feed intake. Br J Nutr (1997) 1.05
Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J Mol Biol (2003) 1.05
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg (1996) 1.05